SYK Net Income Growth
Period ending:
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
SYK net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 157 observations from Jun 30, 1987 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 27.793% | |
| 16.7191% | |
| 8.4531% | |
| -18.0223% | |
| -15.3712% | |
| -14.936% | |
| -5.4344% | |
| 38.8781% | |
| 27.2794% | |
| 27.9406% | |
| 34.2239% | |
| 5.2096% | |
| 30.303% | |
| 30.3722% | |
| 18.2548% | |
| 29.3158% | |
| -0.192% | |
| 43.1108% | |
| 24.7029% | |
| 8.2005% | |
| 30.1062% | |
| -34.9353% | |
| -23.2357% | |
| -48.7449% | |
| -54.9014% | |
| -38.5576% | |
| -41.3735% | |
| 177.1845% | |
| 228.7037% | |
| 245.633% | |
| 248.3333% | |
| -30.5228% | |
| -36.4706% | |
| -39.6684% | |
| -38.0692% | |
| 7.2333% | |
| 5.919% | |
| 4.4527% | |
| 14.4545% | |
| 40.9516% | |
| 72.0257% | |
| 113.8889% | |
| 139.0365% | |
| 61.6758% | |
| 20.5426% | |
| -2.0725% | |
| -40.159% | |
| -18.2022% | |
| -32.1053% | |
| -38.3387% | |
| -22.4961% | |
| -37.7187% | |
| -18.7455% | |
| -9.7983% | |
| -3.4944% | |
| 15.3349% | |
| 12.3299% | |
| 10.3339% | |
| 5.6808% | |
| -3.4821% | |
| 6.2346% | |
| 9.5819% | |
| 14.9269% | |
| 18.9602% | |
| 4.609% | |
| 0.8433% | |
| -3.5198% | |
| -5.8541% | |
| 2.0707% | |
| -12.7328% | |
| -8.6001% | |
| -5.0845% | |
| -5.5579% | |
| 49.8392% | |
| 61.7674% | |
| 64.5007% | |
| 74.5882% | |
| 37.8186% | |
| 18.1044% | |
| 15.7339% | |
| 26.4773% | |
| 25.6115% | |
| 41.1424% | |
| 45.1155% | |
| -0.4713% | |
| 3.6266% | |
| 2.6902% | |
| 2.7262% | |
| 35.9559% | |
| 31.6603% | |
| 31.2211% | |
| 34.4392% | |
| 28.3553% | |
| 29.8802% | |
| 29.5352% | |
| 23.4881% | |
| 23.4267% | |
| 21.6459% | |
| 20.724% | |
| 29.2486% |
Compare net income growth
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) net income growth
- Johnson & Johnson (JNJ) net income growth
- AbbVie (ABBV) net income growth
- UnitedHealth Group (UNH) net income growth
- Merck & Co. (MRK) net income growth
- Thermo Fisher Scientific (TMO) net income growth
- Amgen (AMGN) net income growth
- Gilead Sciences (GILD) net income growth
Compare all covered stocks by net income growth →
All SYK financial metrics · SYK stock overview · How to interpret financial metrics